- Home
- PAGP vs NARI Comparison
PAGP vs NARI Comparison
Compare PAGP & NARI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAGP
- NARI
- Stock Information
- Founded
- PAGP 2013
- NARI 2011
- Country
- PAGP United States
- NARI United States
- Employees
- PAGP N/A
- NARI N/A
- Industry
- PAGP Natural Gas Distribution
- NARI Medical/Dental Instruments
- Sector
- PAGP Energy
- NARI Health Care
- Exchange
- PAGP Nasdaq
- NARI Nasdaq
- Market Cap
- PAGP 4.2B
- NARI 4.7B
- IPO Year
- PAGP 2013
- NARI 2020
- Fundamental
- Price
- PAGP $21.68
- NARI N/A
- Analyst Decision
- PAGP Buy
- NARI Hold
- Analyst Count
- PAGP 10
- NARI 12
- Target Price
- PAGP $20.44
- NARI $69.22
- AVG Volume (30 Days)
- PAGP 1.9M
- NARI 1.2M
- Earning Date
- PAGP 02-07-2025
- NARI 03-03-2025
- Dividend Yield
- PAGP 7.01%
- NARI N/A
- EPS Growth
- PAGP N/A
- NARI N/A
- EPS
- PAGP 0.73
- NARI N/A
- Revenue
- PAGP $50,073,000,000.00
- NARI $574,498,000.00
- Revenue This Year
- PAGP $16.20
- NARI $24.62
- Revenue Next Year
- PAGP N/A
- NARI $18.00
- P/E Ratio
- PAGP $29.61
- NARI N/A
- Revenue Growth
- PAGP 2.79
- NARI 22.41
- 52 Week Low
- PAGP $16.90
- NARI $36.73
- 52 Week High
- PAGP $22.31
- NARI $79.99
- Technical
- Relative Strength Index (RSI)
- PAGP 60.17
- NARI 5.14
- Support Level
- PAGP $20.55
- NARI $79.76
- Resistance Level
- PAGP $21.06
- NARI $79.99
- Average True Range (ATR)
- PAGP 0.42
- NARI 0.07
- MACD
- PAGP -0.02
- NARI -5.93
- Stochastic Oscillator
- PAGP 79.58
- NARI 0.00
About PAGP Plains GP Holdings L.P. Units representing Limited Partner Interests
Plains All American provides transportation, storage, processing, fractionation, and marketing services for crude oil, refined products, natural gas liquids, liquefied petroleum gas, and related products. Plains' assets span the United States and Alberta, Canada, but are heavily concentrated in the Permian Basin.
About NARI Inari Medical Inc.
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.